临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2009年
7期
17-18
,共2页
伊曲康唑%凝胶%醇质体%透皮给药
伊麯康唑%凝膠%醇質體%透皮給藥
이곡강서%응효%순질체%투피급약
Itraconazole%gel%ethosome%transdermal drug delivery
目的 考察醇质体凝胶作为伊曲康唑透皮给药载体的可行性.方法 采用注入法制备伊曲康唑醇质体进而用卡波姆制备成凝胶,采用透皮扩散试验仪对大鼠皮肤进行体外经皮渗透实验;以HPLC测定药物含量求算积累渗透量及稳态透皮速率,并测定药物在皮肤表皮和真皮中的滞留量.结果 伊曲康唑醇质体凝胶的经皮渗透率是其水溶液的9.20倍,是体积分数为30%乙醇环糊精溶液的1.97倍.结论 醇质体凝胶能提高伊曲康唑的透皮速率,增加药物在皮肤内的滞留量.
目的 攷察醇質體凝膠作為伊麯康唑透皮給藥載體的可行性.方法 採用註入法製備伊麯康唑醇質體進而用卡波姆製備成凝膠,採用透皮擴散試驗儀對大鼠皮膚進行體外經皮滲透實驗;以HPLC測定藥物含量求算積纍滲透量及穩態透皮速率,併測定藥物在皮膚錶皮和真皮中的滯留量.結果 伊麯康唑醇質體凝膠的經皮滲透率是其水溶液的9.20倍,是體積分數為30%乙醇環糊精溶液的1.97倍.結論 醇質體凝膠能提高伊麯康唑的透皮速率,增加藥物在皮膚內的滯留量.
목적 고찰순질체응효작위이곡강서투피급약재체적가행성.방법 채용주입법제비이곡강서순질체진이용잡파모제비성응효,채용투피확산시험의대대서피부진행체외경피삼투실험;이HPLC측정약물함량구산적루삼투량급은태투피속솔,병측정약물재피부표피화진피중적체류량.결과 이곡강서순질체응효적경피삼투솔시기수용액적9.20배,시체적분수위30%을순배호정용액적1.97배.결론 순질체응효능제고이곡강서적투피속솔,증가약물재피부내적체류량.
Objective To investigate the feasibility of ethosmoe gel as transdemal carries of ltraconazole. Methods Itraconazole was encapsulated in ethosomes composed of phospholipids and ethanol, then ethosomes were incorporated in earbopol gel. Percutaneous perme-ation of Itraconazole was observed using rat skin and Franz transdermal diffusion device in vitro. The concentration of Itraconazole in receptor compartment at specified time points were determined by HPLC. The steady flux and the accumulation quantity of Itraconazole in epidermis and dermis were calculated. Results The flux of Itraconazole from ethosome gel were 9.20, and 1.97 times higher than that from aqueous solu-tion, 30% ethanol HP-β-CD solution gel preparation, respectively. Conclusion Ethosome gel is effective for transdemal delivery and increased the Itraconazole amount retained in the skin.